We were unable to conduct an equivalent evaluation here because of the handful numbers of patients with p16-positive/ HPV-positive HNSCC and the relatively small number of subjects in the OPSCC subgroup. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.